NMDA receptor subunit 1 (NR1) expression in the chicken cochlear nuclei was examined using immunohistochemistry and quantitative Western blots. An antibody raised in mouse against a highly conserved domain of NR1 recognized the same 115 kDa protein band in chicken brain. Quantitative Western blotting of cochlear nucleus protein showed no significant change in NR1 expression from E18 to adult. The nucleus angularis (NA) initiated NR1 expression before E12 that became more prominent after hatching. NR1-ir first appeared in the nucleus magnocellularis (NM) and nucleus laminaris (NL) at E10. From E12 to E19, NM exhibited a gradient in NR1 expression with medial, higher best frequency cell bodies being more immunoreactive than lateral, lower best frequency cell bodies. This gradient disappeared by E20. The distribution of NR1 in NL also changed during development. NR1 label was present in NL cell bodies between E10 and E13. From E14 onwards, NR1-ir characterized both cell bodies and neuropil. After hatching, NR1-ir levels were higher in NL than NM. The superior olive first expressed NR1 at E12. Neuropil staining was more intense than cell bodies until after hatching. In contrast to the functional decrease observed in mammals and chick, NR1-ir expression remained high in the chicken auditory brainstem into adulthood. Both chickens and rodents retain high levels of NR-1.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3269632 | PMC |
http://dx.doi.org/10.1016/j.heares.2004.01.007 | DOI Listing |
Metab Brain Dis
January 2025
Department of Pharmacy, the Second Affiliated Hospital of Shaoyang University, Shaoyang, Hunan, China.
Alzheimer's disease (AD) is characterized by the accumulation of amyloid-β (Aβ) plaques and the aggregation of tau protein, resulting in intense memory loss and dementia. Diabetes-associated cognitive dysfunction (DACD) is a complication of diabetes mellitus, which is associated with decreased cognitive function and impaired memory. A growing body of literature emphasize the involvement of microglia in AD and DACD.
View Article and Find Full Text PDFPhytother Res
January 2025
School of Chemical Engineering and Physical Sciences, Lovely Professional University, Phagwara, India.
Psoriasis is a noncontagious, autoimmune chronic inflammatory disease with an unknown root cause. It is classified as a multifactorial and chronic skin disorder that also affects the immune system and is genetic. Environmental factors such as stress, infections, and injuries all play an important role in the disease's development.
View Article and Find Full Text PDFChempluschem
January 2025
Dmitry Mendeleev University of Chemical Technology of Russia, EMCPS Department, Miusskaya sq.9, 125047, Moscow, RUSSIAN FEDERATION.
Although microbial fuel cells (MFC) could be a promising energy source, their implementation is largely limited by low performance. There are several approaches to overcome this issue. For example, MFC performance can be enhanced using redox mediators (RM) capable of transferring electrons between microorganisms and MFC electrodes.
View Article and Find Full Text PDFCNS Neurosci Ther
January 2025
Department of Psychiatry, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Objective: Alzheimer's disease (AD) and dementia with Lewy bodies (DLB) are common neurodegenerative diseases with distinct but overlapping pathogenic mechanisms. The clinical similarities between these diseases often result in high misdiagnosis rates, leading to serious consequences. Peripheral blood mononuclear cells (PBMCs) are easy to collect and can accurately reflect the immune characteristics of both DLB and AD.
View Article and Find Full Text PDFCell Commun Signal
January 2025
Department of Anesthesiology, Cheeloo College of Medicine, Qilu Hospital (Qingdao), Shandong University, 758 Hefei Road, Qingdao, China.
Oxidative stress and neuroinflammation are recognized as key factors in the development of neurodegenerative diseases, yet effective interventions and biomarkers to address oxidative stress and neuroinflammation in these conditions are limited. Uric acid (UA), traditionally associated with gout, is now gaining prominence as a potential target in neurodegenerative diseases. Soluble UA stands out as one of the most vital antioxidant compounds produced by the human body, accounting for up to 55% of the extracellular capacity to neutralize free radicals.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!